Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials

被引:0
|
作者
Lauren A. Marcath
Taylor D. Coe
Emily K. Hoylman
Bruce G. Redman
Daniel L. Hertz
机构
[1] University of Michigan,Department of Clinical Pharmacy
[2] College of Pharmacy,Department of Internal Medicine – Hematology/Oncology
[3] University of Michigan,undefined
[4] Michigan Medicine,undefined
来源
BMC Cancer | / 18卷
关键词
Oncology clinical trial drug interaction;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
    Marcath, Lauren A.
    Coe, Taylor D.
    Hoylman, Emily K.
    Redman, Bruce G.
    Hertz, Daniel L.
    BMC CANCER, 2018, 18
  • [2] Impact of medication reconciliation for patients enrolled in oncology early phases clinical trials: A drug-drug interactions retrospective study
    Malifarge, L.
    Deppenweiler, M.
    Italiano, A.
    Lortal, B.
    ANNALS OF ONCOLOGY, 2020, 31 : S1057 - S1057
  • [3] Prevalence of clinically relevant drug-drug interactions in patients enrolled in NCTN clinical trials.
    Marcath, Lauren A.
    Coe, Taylor D.
    Hoylman, Emily K.
    Redman, Bruce G.
    Hertz, Daniel Louis
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Drug-drug interactions in oncology - prevalence and clinical relevance
    Hinnerkort, A.
    Liekweg, A.
    Muellerleile, U.
    Tiede, S.
    Bruellke, N.
    Jaehde, U.
    ONKOLOGIE, 2010, 33 : 1 - 1
  • [5] Concomitant drugs with low risks of drug-drug interactions for use in oncology clinical trials
    Ranchon, Florence
    Vial, Thierry
    Rioufol, Catherine
    Henin, Emilie
    Falandry, Claire
    Freyer, Gilles
    Trillet-Lenoir, Veronique
    Le Tourneau, Christophe
    You, Benoit
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 94 (02) : 189 - 200
  • [6] Realization of video for patients enrolled in oncology clinical trials
    Bondarenko, M.
    Peyron, F.
    Barlesi, F.
    Bues-Charbit, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 880 - 880
  • [7] A Database of Drug Repurposing Clinical Trials in Oncology
    Pantziarka, Pan
    Vandeborne, Liese
    Bouche, Gauthier
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] An Analysis of Japanese Patients Enrolled in Multiregional Clinical Trials in Oncology
    Akihiro Hirakawa
    Fumie Kinoshita
    Therapeutic Innovation & Regulatory Science, 2017, 51 : 207 - 211
  • [9] An Analysis of Japanese Patients Enrolled in Multiregional Clinical Trials in Oncology
    Hirakawa, Akihiro
    Kinoshita, Fumie
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2017, 51 (02) : 207 - 211
  • [10] Drug-drug interactions in pediatric oncology patients
    Balk, T. E.
    van der Sijs, I. H.
    van Gelder, T.
    Janssen, J. J. B.
    van der Sluis, I. M.
    van Leeuwen, R. W. F.
    Engels, F. K.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (07)